These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 849606)

  • 41. In vivo immune response suppression by the supernatant from concanavalin A-activated spleen cells.
    Reinertsen JL; Steinberg AD
    J Immunol; 1977 Jul; 119(1):217-22. PubMed ID: 326957
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Blocking action of the soluble H-2 antigens and H-2 antibody isolated by various methods and mouse immune lymphocytes].
    Pletneva TP; Khorobrykh VV; Kaulen DR
    Zh Mikrobiol Epidemiol Immunobiol; 1979 Aug; (8):68-72. PubMed ID: 386657
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Induction of high-grade tumor-specific immunity in a host using a cytotoxic T-lymphocyte clone specific for a stable tumor antigen on murine leukemia L1210.
    Rahman SM; Kawashima K; Nakashima I; Nagase F
    Cancer Res; 1988 Nov; 48(22):6450-4. PubMed ID: 3263189
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The role of the BCG dose and the mouse strain in the inhibition of development of neoplasms susceptible and nonsusceptible to the action of natural cytotoxic cells.
    Skórski T
    Folia Histochem Cytobiol; 1985; 23(1-2):3-10. PubMed ID: 4043437
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Characterization of suppressor cells in mice bearing syngeneic mastocytoma.
    Takei F; Levy JG; Kilburn DG
    J Immunol; 1977 Feb; 118(2):412-7. PubMed ID: 65423
    [TBL] [Abstract][Full Text] [Related]  

  • 46. In vitro depression of cellular immunity by Friend virus leukemic spleen cells.
    Toy ST; Whellock EF
    Cell Immunol; 1975 May; 17(1):57-73. PubMed ID: 1168547
    [No Abstract]   [Full Text] [Related]  

  • 47. Adoptive immunotherapy in BALB-c times DBA-2 Cr F1 mice bearing an immunogenic subline of L1210 leukemia.
    Nicolin A; Canti G; Goldin A
    Cancer Res; 1974 Nov; 34(11):3044-8. PubMed ID: 4424774
    [No Abstract]   [Full Text] [Related]  

  • 48. Depression of afferent arc of the in vivo cytotoxic T-cell immunity by bacterial lipopolysaccharides.
    Mizoguchi K; Nakashima I; Hasegawa Y; Isobe K; Kato N; Shimokata K; Kawashima K; Nagase F; Ando K; Yoshida T
    Cell Immunol; 1985 Oct; 95(2):330-9. PubMed ID: 2931181
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Prevention of friend virus leukemogenesis by concanavalin A. I. Detection of dormant virus and role of humoral antibody in protected mice.
    Kateley JR; Friedman H
    J Natl Cancer Inst; 1974 Jul; 53(1):151-8. PubMed ID: 4835102
    [No Abstract]   [Full Text] [Related]  

  • 50. Monoclonal antibody-recognizing tumor-associated antigen of DBA/2 mouse lymphoma L1210 and its sublines.
    Fuji H
    Transplant Proc; 1980 Sep; 12(3):388-90. PubMed ID: 6784299
    [TBL] [Abstract][Full Text] [Related]  

  • 51. In vivo and in vitro macrophage activation by systemic adjuvants.
    Bruley-Rosset M; Florentin I; Mathé G
    Agents Actions; 1976 Feb; 6(1-3):251-5. PubMed ID: 782207
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Splenic foci of cytotoxic lymphocytes in a graft-versus-host reaction.
    Skinner MA; Marbrook J; Baguley BC
    Int Arch Allergy Appl Immunol; 1978; 56(4):334-43. PubMed ID: 24592
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Involvement of cytotoxic T-lymphocytes in the antitumor activity of spergualin against L1210 cells.
    Umezawa H; Nishikawa K; Shibasaki C; Takahashi K; Nakamura T; Takeuchi T
    Cancer Res; 1987 Jun; 47(12):3062-5. PubMed ID: 3495325
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Common leukemia-associated antigen of DBA/2 mouse leukemia detected by tumor rejection and complement-dependent cytotoxicity assays.
    Kawashima K; Takeyama H; Takahashi T; Kato Y; Watanabe E; Suzuki H; Minam S; Isobe K; Yamada K; Ito Y
    Gan; 1979 Dec; 70(6):769-76. PubMed ID: 94022
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Immunostimulatory factors specifically associated with a spontaneously regressing tumor subline of the murine leukemia L1210.
    Koo PH
    J Immunol; 1981 Jul; 127(1):373-9. PubMed ID: 7016996
    [No Abstract]   [Full Text] [Related]  

  • 56. [Phagocytic function of the macrophages in leukemic animals].
    Fan FF
    Eksp Med Morfol; 1976; 15(2):83-8. PubMed ID: 1278085
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Tuftsin: an immunomodulating peptide hormone and its clinical potential as a natural biological response modifier.
    Nishioka K; Amoscato AA; Babcock GF; Banks RA; Phillips JH
    Cancer Invest; 1984; 2(1):39-49. PubMed ID: 6322938
    [No Abstract]   [Full Text] [Related]  

  • 58. Suppression of cytotoxic T lymphocytes by carrageenan-activated macrophage-like cells.
    Yung YP; Cudkowicz G
    J Immunol; 1978 Nov; 121(5):1990-7. PubMed ID: 309486
    [No Abstract]   [Full Text] [Related]  

  • 59. The effects of passive immunization with tumor-specific antiserum on the active immune response of mice to sublines of leukemia L1210.
    Carlson GA; Terres G
    J Immunol; 1978 Nov; 121(5):1752-9. PubMed ID: 712064
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Requlation of cytotoxic lymphocyte responses in New Zealand mice by alloantigen-activated spleen cells.
    Huston DP; Rich RR; Steinberg AD; Truitt GA
    J Immunol; 1979 Apr; 122(4):1476-81. PubMed ID: 448096
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.